Sensitive ASX Announcement

Clinuvel receives approval to begin Ph II Solar Urticaria

Published: 11/06/08, 09:45am (AEST)3 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only